Daffodil Health

The firm's primary business involves providing a Software-as-a-Service (SaaS) platform that leverages artificial intelligence and large language models to automate healthcare administration processes. Specifically, Daffodil Health targets the out-of-network (OON) and Reference-Based Pricing (RBP) processes for payers and Third-Party Administrators (TPAs). The business model is centered on offering this AI-powered solution to streamline operations and generate cost savings for its clients. By automating these functions, the company aims to eliminate the need for costly intermediaries and simplify billing procedures.

The core product is an AI/LLM-enabled SaaS Repricer, launched in 2024. Its key features include the real-time repricing of claims according to the payer's or TPA's specific pricing methodology, simplified configuration of complex pricing regulations, and automatic benchmarking of repriced claims for accuracy. A distinguishing characteristic is its ability to generate detailed and defensible rationales for the pricing decisions made by its AI models. This functionality directly addresses the opaque and complex nature of US healthcare pricing. The company secured a significant milestone in May 2024, raising $4.6 million in a seed funding round led by Maverick Ventures with participation from Epic Ventures, which will be used to expand operations and development.